Magnetic resonance image contrast enhancement

Magnetic resonance image contrast enhancement refers to the increased visibility of internal structures on MRI scans facilitated by the use of agents (most commonly gadolinium-based contrast agents, GBCAs) that alter local magnetic environments. These agents work by shortening the T1 (and to a lesser extent, T2) relaxation times of water protons in tissues, thereby changing signal intensity and improving lesion or tissue differentiation on images. The effect is a pharmacologically or physicochemically induced imaging phenomenon, not the property of a single biological molecule or receptor. The relevant "interacting drugs" are the various gadolinium chelates and less commonly manganese or iron-based agents[1][2][5][6]. This term should not be treated as a molecular target itself—it represents the output of using molecular agents within MRI, not a unique biological target.

Other names

MRI contrast enhancementMRI contrast agent effectMRI signal enhancement